INTRODUCTION
Dynamic post-translational regulation of protein function can occur through a combination of a variety of reversible modifications. SUMOylation is a versatile regulatory mechanism of protein function that can confer an alteration in function, location and/or half-life. Small ubiquitin-like modifier (SUMO) is a member of the ubiquitin-like protein superfamily. There are, to date 4 isoforms, found in human cells: SUMO-1, -2, -3 and -4. SUMO-1 is an 11kDa polypeptide that shares only 18% sequence homology with ubiquitin. However, NMR studies revealed the characteristic ββαββαβ ubiquitin fold and a nearly overlapping tertiary structure (1) . The most prominent difference between the SUMO family and ubiqutin is a flexible N terminal extension with unknown function, though it has been suggested that it may confer specific protein/protein interactions. SUMO-1 shares 48% homology with SUMO-2 and 46% homology with SUMO-3, whereas SUMO-4 has 86% sequence homology with SUMO-2, but phylogenic analysis revealed that SUMO-4 has highest functional property homology with SUMO-1 (2) . However, very little is known about the functional differences between SUMO-1, -2, -3 and -4.
The SUMO family proteins are attached to target proteins by a series of conjugating enzymes similar to those found in the ubiquitin conjugation system. Like ubiquitin they are synthesized as inactive precursors, and first, Ulp-1, a protease cleaves the C terminal of the SUMO polypeptide to reveal a di-glycine motif that is essential for the conjugation of SUMO to the target protein (1) . Then the C-terminal glycine binds to the E1 activating enzyme complex (Aos1/Uba2) via thioester linkage. This is then passed onto the E2 conjugating enzyme (Ubc9) which catalyses the transfer of the SUMO polypeptide on to a lysine on the target protein. The E3 ligase facilitates this transfer. There are number of E3 ligases and, if the similarities with the ubiqutin system persist, many of these will also have a structural role in presentation of the target and Ubc9. The reversibility of the conjugation is given by the isopeptidases (SenP family) that can cleave SUMO from the target protein. The specificity for the lysine that becomes SUMOylated is often promoted by a consensus binding motif that determines the interaction of the target with Ubc 9 (3). The consensus sequence (ΨKXE) consists of a hydrophobic amino acid (Ψ preferably leucine, isoleucine or valine), a lysine (K), any amino acid (X) and a glutamic acid (E). SUMO-2, -3 and -4 contain an internal consensus binding motif and so can be SUMOylated themselves making it possible for SUMO chains. However, SUMO-1 does not contain the consensus binding sequence and thus conjugation of SUMO-1 to a target protein will result in mono-SUMOylation or the termination of a chain.
Protein function can be modulated by the addition of a SUMO protein, but also by interaction with a SUMOylated protein. These downstream interacting effector proteins may have a SUMO interacting motif (SIM). These motifs have a consensus sequence that consists of a hydrophobic core sequence V/I-V/I-X-V/I, where X equates often to an acidic residue that is often associated with a stretch of acidic residues flanking either its N or C terminus (4) . For example, SIM containing protein Srs2 interacts with SUMOylated PCNA to pre-http://bmbreports.org BMB reports vent unwanted recombination events in replicating chromosomes (5).
Neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease, have common features of aggregation or accumulation of proteins and these are thought to play a key role in disease pathogenesis (6) . SUMO proteins have been co-localised to neurones containing protein aggregates (7) . It has been hypothesized that: the SIMs may help in the aggregation; that SUMOylation may compete for proteasomal degradation by using the same lysine residues as those for ubiquitin mediated degradation; or that SUMOylation of molecular chaperones may play a role in neurodegenerative disease pathologies.
Redox effects on the conjugation of a SUMO group could tip the balance of signalling in favour of a particular outcome. Particularly, high concentrations of hydrogen peroxide (100 mM) increase SUMOylation (8), probably via inhibition of the isopeptidases that reverse SUMOylation. While at concentrations lower than 1mM hydrogen peroxide cause formation of a disulphide bridge between Uba2 and Ubc9, contain active site cysteines, and which are sensitive to the redox environment of the cell (9). Furthermore very low concentrations of hydrogen peroxide (10 μM) have minimal effects of the conjugation machinery and changes to the SUMO proteome are mostly likely to alter signalling cascades (9), for instance through redox sensitive phosphatases. In particular, both oxidants, such as hydrogen peroxide (H2O2), and antioxidants have been shown to have cellular roles as second messengers, passing signals from the outside of the cell to the nucleus and via transcription activation elicit downstream changes in the proteome (10) . Previously, Grant et al. (2005) (11) showed that both ascorbate (100 μM) and hydrogen peroxide (100 μM) can modulate the total and oxidised proteomes of the neuroblastoma SH-SY5Y cell line, a cell line previously used to study oxidative stress neurodegeneration models. Numerous transcription factors can be SUMOylated and due to the redox sensitive nature of the SUMOylation machinery (9) it is hypothesized that these chemicals could mediate cellular changes by altering SUMOyaltion patterns. Thus, this paper identifies proteins that are SUMOylated in response to the oxidant hydrogen peroxide or the antioxidant ascorbate in neuroblastoma cells by electospray ionisation fourier transform ion cyclotron resonance mass spectrometry (ESI-FT ICR MS).
RESULTS
To assess SUMOyaltion in SH-SY5Y cells, cells were treated with PBS, ascorbate (100 μM) or hydrogen peroxide (100 μM). Proteins were vizualised by Coomassie Blue staining and proteins between 25-55 kDa were excised from each lane (Fig. 1) . Mass spectral analysis identified 97 proteins from the PBS http://bmbreports.org Table 1 and Fig. 2 shows there was a great overlap between all treatments (55 proteins). Predicted SUMOylation sites were determined and this revealed that approximately 70% (120 out of 169) of all the proteins identified contained a consensus sequence for SUMOylation. The 26S protease regulatory subunit 6A (PSMC3) that was identified in hydrogen peroxide treatment alone was verified using immunoprecipitation of PSMC3 and detection with SUMO1 antibody by Western blotting (Fig. 3) . It was not possible to identify the protein in whole cell lysates. Proteins identified that did not contain a SUMOylation consensus sequence (49 out of 169, Table 1 ) may have co-immunoprecipitated with SUMOylated proteins or could contain a SIM. Proteins not containing a SUMOylation consensus sequence were searched for known SIM sequences. This identified six proteins with one or more potential SIM sequences (Table 1) .
DISCUSSION
In this study 169 proteins were identified, and of these 120 were predicted to have SUMO consensus sequences. Although an approach using large numbers of cells was used instead of a transfected tagging system these numbers are comparable to previous proteomic studies of mammalian cell lines (HEK293: 122 protein identified (12); HeLa cells: 53 proteins identified (13) ) and in yeast cells (141 proteins identified (14); 271 proteins identified (15)). However, here only a fraction of the total cell lysate was analysed (25-55 kDa) and thus many more proteins have potentially not been identified. The use of highly sensitive and accurate FT-ICR mass spectrometry may have aided in the detection of so many proteins found here. The use of a quantitative technique, such as iTRAQ or SILAC, will also aid in future comparative studies.
Some proteins detected by mass spectrometry and that were subsequently examined for SUMOylation consensus sequence did not contain one. These proteins could either have been co-immunopreciptated with other proteins that were SUMOylated or perhaps contain SUMO interacting motifs (SIMs). Co-immunoprecipitating proteins are a common problem with immunoprecipitation protocols (16) , and as seen here homologous proteins of the same family (eg heterogeneous nuclear ribonucleoproteins (hnRNPs), with and without SUMOyaltion consensus sequences could be precipitated from complexes that are not disrupted by the isolation techniques employed. Although the hnRNPs are some of the most abundant RNAbinding proteins (17) , as found previously (18) many of the proteins found here are involved in RNA metabolism and thus it may not be helpful to simply discard any proteins without SUMO consensus sequences.
The functions of SUMOylation are often mediated by downstream effector proteins (19) containing SIMs. These motifs are composed of a hydrophobic core and a stretch of acidic residues at either the N or C terminus (20) and confer a region that can bind SUMO (21) . Rudimentary analysis of sequences from proteins without SUMO consensus sequences for SIM consensus sequences identified three actin species, aspartyl-tRNA synthetase, delta-1-pyrroline-5-carboxylate synthetase and sortilin as proteins with potential SIMs. However, this would have to be confirmed by further analysis.
The proteins found can broadly be assigned to: DNA associated proteins, such as histones, and transcription factors; RNA associated proteins, such as the heterogeneous nuclear ribonucleoproteins and RNA helicases; structural proteins, such as actin and tubulin; and proteasomal proteins. As would be expected the majority of the proteins are nuclear proteins and for the greater part these proteins have already been identified or proteins with similar functions have already been identified in screens for SUMOylated proteins (12, 13, 22) . Cells were treated with hydrogen peroxide, inducing oxidative stress, as evidenced by the presence of topoisomerase II in extracts of these cells. This protein has previously been identified as a SUMOylation target that might be involved in DNA repair (23) . The larger number of proteins seen in the hydrogen peroxide treatment (133) compared with the PBS control (97) or the ascorbate treatment (94) indicate that at the concentration used, Uba2 and Ubc9 are not inactivated, in contrast to results of Bossis & Melchior, 2006 (9) . This may be due to differences in cell density or volumes of media between the current study and that of Bossis & Melchior (9) .
Upon examining the proteins that were identified by the different treatments employed in this study, the PBS and ascorbate treatments revealed very similar groups. SUMOylated proteins that were present in hydrogen peroxide or ascorbate http://bmbreports.org treated cells that stood out were the proteasomal proteins. Of particular interest is the protein 26S proteasome regulatory subunit 6A, which is also known as TBP-1 or PSMC3 which was found in hydrogen peroxide treated cells only. Western blotting verified PSMC3 as SUMOylated in hydrogen peroxide treated cells, but also a small amount was found in untreated cells. (22, 24) have already demonstrated that this protein can be SUMOylated in a plasmid directed Ubc9 fusion dependent SUMOylation system. However, this may be the first time that it has been isolated as SUMOylated by cellular machinery. It is of particular interest because, although TBP-1/PSMC3 has been identified as part of the proteasomal equipment, it is also thought to have other functions such as control of transcription. Interaction of TBP-1/PSMC3 with oxidative stress induced transcription factor p19 ARF causes stabilisation of p19 ARF which may assist with check point responses to oxidative stress (25) . Other proteasomal proteins were associated with ascorbate or hydrogen peroxide treatments, whether these too have further functions than protein degradation in regards to SUMOylation remains to be determined.
In conclusion, many proteins have been identified here from the SH-SY5Y neuroblastoma cell line in response to antioxidant or oxidative challenges. These have included proteins containing SUMOylation consensus sequences and potential interacting proteins either through complexes or SIMs. The sensitivity of the instrumentation used represents a way forward to finding novel SUMO targeted proteins in untransfected cells.
MATERIALS AND METHODS

Cell culture
Neuroblastoma cells (SH-SY5Y) were cultured using RPMI 1640 with Glutamax I (Gibco BRL, Grand Island, NY, USA) supplemented with fetal bovine sera (15%; Gibco) and nonessential amino acid solution (1%; Sigma, St. Louis, MO, USA).
Protein isolation and mass spectral analysis
For protein isolation, SH-SY5Y cells (10×10 6 ) were treated with PBS, ascorbate (100 μM) or hydrogen peroxide (100 μM) for 30 min and then extracted into ice cold RIPA buffer containing protease inhibitor cocktail (Complete mini, Roche). Cell experiments were performed three times and extracts were pooled prior to immunoprecipitation using a mouse mAb directed against human SUMO-1 (Abgent, Cambridge, UK; 4 o C, 1 h) or mouse isotype IgG control antibody (Sigma) coupled to Protein G Dynabeads (Invitrogen, Paisley UK). After extensive washing immunoprecipitated proteins were separated by SDS-PAGE and proteins were stained with Imperial Coomassie Blue stain (Thermofisher, UK). Gel (between 25-55 kDa) was excised, tryptically digested and peptides extracted (26) . On-line liquid chromatography was performed by use of a C8 column and separated over a 60-min water: acetonitrile gradient. Peptides were eluted directly into a Thermo Finnegan LTQ FT mass spectrometer. Collision induced dissociation was performed with helium gas, as previously described (27) . Data were analysed using Mascot software (version 2.2.04) and the SwissProt (version 56.3) human database, with a mass tolerance of 0.5 kDa and cysteine carbamidomethylation; glutamine or asparagine deamidation; methionine oxidation; serine, threonine or tryrosine phosphorylation as possible modifications.
Immunoprecipitation and Western blotting of PSMC3
Proteins were isolated as described above using PSMC3 antibody (Abcam, UK) and separated by SDS-PAGE. Gels were electroblotted to PVDF and proteins were detected with mouse mAb directed against human SUMO-1 (Abgent, Cambridge, UK) and horse radish peroxidise secondary antibody. Protein bands were visualised using chemiluminescence (Supersignal West Pico, Pierce, UK).
Data analysis
Venn diagram was drawn using EulerVennApplet http://www. cs.kent.ac.uk/people/staff/pjr/EulerVennCircles/EulerVenn Applet.html, (28) . SUMOylation consensus sequence site prediction was accomplished using SUMOsp 2.0 (29) . Potential SIMs were determined by searching FASTA sequences of proteins without SUMOylation consensus sequences for known SIM sequences (5) .
